These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1107725)

  • 1. Lepromatous leprosy in the nose after one year of dapsone treatment: clinical and bacteriological findings.
    Barton RP; Hogerzeil LM
    Lepr Rev; 1975 Dec; 46(4):257-65. PubMed ID: 1107725
    [No Abstract]   [Full Text] [Related]  

  • 2. Lepromatous leprosy in the nose after one year of dapsone treatment: histopathological findings.
    McDougall AC; Weddell AG; Rees RJ
    Lepr Rev; 1975 Dec; 46(4):267-77. PubMed ID: 1107726
    [No Abstract]   [Full Text] [Related]  

  • 3. Importance of nasal lesions in early lepromatous leprosy.
    Barton RP
    Ann R Coll Surg Engl; 1975 Dec; 57(6):309-12. PubMed ID: 1108744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli.
    Waters MF; Rees RJ; McDougall AC; Weddell AG
    Lepr Rev; 1974 Dec; 45(4):288-98. PubMed ID: 4613977
    [No Abstract]   [Full Text] [Related]  

  • 5. The histopathology of lepromatous leprosy in the nose.
    McDougall AC; Rees RJ; Weddell AG; Kanan MW
    J Pathol; 1975 Apr; 115(4):215-26. PubMed ID: 1099180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How much non-infectious are the "non-infectious" lepromatous leprosy patients?
    Prabhakar MC; Appa Rao AV; Krishna DR; Ramanakar TV
    Lepr India; 1983 Jul; 55(3):576-83. PubMed ID: 6361383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose dapsone therapy in lepromatous leprosy.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):89-92. PubMed ID: 1100970
    [No Abstract]   [Full Text] [Related]  

  • 8. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
    Levy L; Shepard CC; Fasal P
    Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
    [No Abstract]   [Full Text] [Related]  

  • 9. The continuous bacteremia of lepromatous leprosy.
    Drutz DJ; Chen TS; Lu WH
    N Engl J Med; 1972 Jul; 287(4):159-64. PubMed ID: 4555967
    [No Abstract]   [Full Text] [Related]  

  • 10. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
    Koticha KK; Sane AB
    Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply: recommending drug regimens to smear negative MB cases after prolonged dapsone monotherapy.
    Noordeen SK
    Lepr Rev; 1991 Sep; 62(3):340. PubMed ID: 1795596
    [No Abstract]   [Full Text] [Related]  

  • 13. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary dapsone-resistant leprosy in Shanghai Municipality.
    Ji BH; Chen JK; Zhang JL; Hou YH; Ni GX; Zhang RB
    Lepr Rev; 1983 Sep; 54(3):197-202. PubMed ID: 6355724
    [No Abstract]   [Full Text] [Related]  

  • 18. Do leprosy patients in Papua New Guinea take their dapsone?
    Ree GH; Taylor VE
    P N G Med J; 1979; 22(2):145-7. PubMed ID: 399578
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
    Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
    [No Abstract]   [Full Text] [Related]  

  • 20. The nose in lepromatous leprosy; bacteriological and histopathological studies of patients treated with dapsone monotherapy for varying periods of time.
    Barton RP; Rees RJ; McDougall AC; Ellard GA
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):58-67. PubMed ID: 7200473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.